Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Options for Treating the High-Risk APL Patient

December 30, 2021
Alan Burnett, MD, takes a look at the combination of ATRA + ATO + GO in high-risk acute promyelocytic leukemia (APL) patients, the complications that APL patients face, and moving away from chemotherapy. For more on these results, read our coverage of the study here.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
November 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals